TARGET AUDIENCE
Hematologists-oncologists, oncologists, physician assistants, nurse practitioners, and oncology nurses involved in the care of patients with acute myeloid leukemia (AML).
EDUCATIONAL OBJECTIVES
Upon completing this activity, the participant will be better able to:
- Describe current and emerging treatments for acute myeloid leukemia (AML)
- Identify diagnostic tests included in standard AML panels, and the role of cytogenetics & molecular analysis
- Utilize risk stratification for treatment planning
- Engage patients & caregivers in clinical trials discussions on emerging therapies for AML
- Apply strategies for optimal patient care
